Navigation Links
HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
Date:7/11/2012

CHARLOTTESVILLE, Va., July 11, 2012 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human surrogate systems for discovery and assessment of new drug compounds, today announced a partnership with the genomic services company Expression Analysis (EA) to develop the first comprehensive database for evaluating the vascular pharmacology of new drug compounds. Using HemoShear's human relevant systems, the database will profile how human vascular cells respond at the genomic level to approximately 75 existing drug compounds that span a wide range of drug classes and have been accepted, black-boxed, or withdrawn from the market.

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO )

"Pharmaceutical companies can use this database to establish a true risk profile of their compounds and investigate potential positive or negative effects. A number of diabetes drugs, for example, have been shown to have adverse cardiovascular effects in humans. We can provide insights about the risks associated with continuing development of new compound candidates by comparing to other drugs in our database that are related by class, genomic signature or mechanism of action," said Nicole Hastings, Ph.D., HemoShear's Vice President of Laboratory Operations. "We partnered with EA because its staff's unrivaled gene expression expertise and throughput are essential to HemoShear's successful and timely development of this landmark database."

EA will generate the database's extensive genomic content by sequencing more than 2,000 human RNA samples. The product will be the transcriptome of each sample, which correlates to the state of the vascular cells in response to a specific drug.

"Sequencing the transcriptome can reveal the expressed quantities of protein-coding messages and isoforms of all active genes as well as detect novel post-transcript
'/>"/>

SOURCE HemoShear LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. HemoShear to Present at Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Conference
2. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
3. Dicom Systems and USARAD.com Announce Partnership and Introduce Beta Version of XMRI.com, New System by USARAD.com
4. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
5. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
6. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
7. Cowen Healthcare Royalty Partners Raises $1 Billion
8. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
9. CoreLab Partners Opens Office in Tokyo, Japan
10. Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award
11. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud ... partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official ... Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific ...
(Date:7/30/2015)... CAMBRIDGE, Mass. , July 30, 2015 /PRNewswire/ ... software solutions for the interpretation and analysis of ... Matthew Fischer has joined the company ... Photo - http://photos.prnewswire.com/prnh/20150730/250931 ... astounding capabilities to integrate, interpret, analyze and explore ...
(Date:7/30/2015)... , July 30, 2015 ... by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, ... & Development, Preclinical, Clinical Trial), by End Users - ... Market is expected to reach USD 2,107.99 million by ... CAGR of 15.29%. Browse more than ...
(Date:7/30/2015)... 2015   Senomyx , Inc. (NASDAQ: SNMX ... to discover, develop, and commercialize novel flavor ingredients for ... financial results for the second quarter 2015. ... remain on track to achieve our commercial and financial ... of the Company. "Since our last quarterly earnings report, ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... assay effectively identifies melanoma, LA JOLLA, Calif., ... diagnostics for the early detection of,melanoma and other ... Cancer Research on its non-invasive assay that distinguishes ... Genomic Assay for,the Detection of Melanoma in Suspicious ...
... CEDAR KNOLLS, N.J., April 15 Emisphere,Technologies, Inc. ... will host its,Annual Stockholders Meeting on Thursday, May ... Two Whippany Road, Morristown, New Jersey. The,meeting will ... TECHNOLOGIES, INC., Emisphere Technologies, Inc. is a ...
... -ARIUS report new data and program updates on cancer stem cell ... ... April 15 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:,ARI), a biotechnology company ... it will be presenting new,findings and program updates related to its ...
Cached Biology Technology:DermTech Study on Melanoma Molecular Diagnostic to Be Presented at AACR 2Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008 2ARIUS presents new findings for anti-cancer antibody programs at AACR 2ARIUS presents new findings for anti-cancer antibody programs at AACR 3ARIUS presents new findings for anti-cancer antibody programs at AACR 4ARIUS presents new findings for anti-cancer antibody programs at AACR 5
(Date:7/21/2015)... July 21, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that it has filed provisional patent 62/192218 ... This invention highlights next generation ... an account, but also the user using unique ...
(Date:7/20/2015)... -- Acuity Market Intelligence,s latest research "The Global Biometrics ... Privacy" forecasts that between 2014 and 2020 nearly ... to smart mobile devices by 2.2 billion mobile ... to generate more than $67.9 billion in total ...    "Biometrics is at the center ...
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION ... new convenient and secure method to make payments.  ... payment methods, introduced with its groundbreaking voice-direct payment ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... Baltimore, MD The human genome shares several peculiarities with the ... Our genetic blueprint contains numerous entities known as transposons, or ... to place on the chromosomes within a cell. ... transposon elements and the decaying remains of former transposons that ...
... meeting of the American Fisheries Society will take place in ... conference is "New Frontiers in Fisheries Management and Ecology: Leading ... http://afs2011.org/ All talks will be at the ... Eat but don,t get eaten: after restoration, young salmon better ...
... discovery by the University of Colorado Boulder and the ... "power plants" within cells known as mitochondria has implications ... and conditions due to mitochondrial defects. Led by ... collaboration with the UC-Davis team led by Professor Jodi ...
Cached Biology News:A 'jumping gene's' preferred targets may influence genome evolution 2A 'jumping gene's' preferred targets may influence genome evolution 3USGS research frontiers on fish at the American Fisheries Society Conference 2USGS research frontiers on fish at the American Fisheries Society Conference 3USGS research frontiers on fish at the American Fisheries Society Conference 4USGS research frontiers on fish at the American Fisheries Society Conference 5USGS research frontiers on fish at the American Fisheries Society Conference 6USGS research frontiers on fish at the American Fisheries Society Conference 7New cellular surprise may help scientists better understand human mitochondrial diseases 2
Request Info...
... CultureWell cell culture systems provide ... cultured cells for staining and ... silicone gaskets preassembled with standard ... plates. The entire system is ...
... The Captivate magnetic separator ... be used in conjunction with ... C-21474, C-21476) or other magnetic ... most 96-well microplates. Cell Biology ...
ANTI L-DOPA...
Biology Products: